SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hyo Jin Choi, Chan Hee Lee, Joo Hyun Lee, Bo Young Yoon, Hyoun Ah Kim, Chang Hee Suh, Sang Tae Choi, Jung Soo Song, Ho Yeon Joo, Sung Jae Choi, Ji Soo Lee, Kee Chul Shin, Han Joo Baek, Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares, International Journal of Rheumatic Diseases, 2014, 17, 6
  2. 2
    Edward Roddy, Hyon K. Choi, Epidemiology of Gout, Rheumatic Disease Clinics of North America, 2014, 40, 2, 155

    CrossRef

  3. 3
    Harmanjot K Grewal, Joseph R Martinez, Luis R Espinoza, Febuxostat: drug review and update, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 5, 747

    CrossRef

  4. 4
    Pascal Richette, Fernando Perez-Ruiz, Michael Doherty, Tim L. Jansen, George Nuki, Eliseo Pascual, Leonardo Punzi, Alexander K. So, Thomas Bardin, Improving cardiovascular and renal outcomes in gout: what should we target?, Nature Reviews Rheumatology, 2014, 10, 11, 654

    CrossRef

  5. 5
    Stefanie Steiger, Jacquie L. Harper, Mechanisms of Spontaneous Resolution of Acute Gouty Inflammation, Current Rheumatology Reports, 2014, 16, 1

    CrossRef

  6. 6
    Mariano Andrés, Francisca Sivera, Eliseo Pascual, Rapid crystal dissolution in gout: is it feasible and advisable?, International Journal of Clinical Rheumatology, 2014, 9, 4, 395

    CrossRef

  7. 7
    L. Cavagna, W. J. Taylor, The Emerging Role of Biotechnological Drugs in the Treatment of Gout, BioMed Research International, 2014, 2014, 1

    CrossRef

  8. 8
    Tony R. Merriman, Hyon K. Choi, Nicola Dalbeth, The Genetic Basis of Gout, Rheumatic Disease Clinics of North America, 2014, 40, 2, 279

    CrossRef

  9. 9
    Rajesh Mohandas, Laura Sautina, Elaine Beem, Anna Schuler, Wai-Yan Chan, John Domsic, Robert McKenna, Richard J. Johnson, Mark S. Segal, Uric acid inhibition of dipeptidyl peptidase IV in vitro is dependent on the intracellular formation of triuret, Experimental Cell Research, 2014, 326, 1, 136

    CrossRef

  10. 10
    Gandikota Girish, Katrina N. Glazebrook, Jon A. Jacobson, Advanced Imaging in Gout, American Journal of Roentgenology, 2013, 201, 3, 515

    CrossRef

  11. 11
    Stephen P. Juraschek, Lara C. Kovell, Edgar R. Miller, Allan C. Gelber, Association of kidney disease with prevalent gout in the United States in 1988–1994 and 2007–2010, Seminars in Arthritis and Rheumatism, 2013, 42, 6, 551

    CrossRef

  12. 12
    H.J.E.M. Janssens, Behalve reumatische artritis ook jicht cardiovasculair riskant, Bijblijven, 2013, 29, 5, 37

    CrossRef

  13. 13
    Stephen P. Juraschek, Edgar R. Miller, Allan C. Gelber, Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010, Arthritis Care & Research, 2013, 65, 1
  14. 14
    G. Savarese, C. Ferri, B. Trimarco, G. Rosano, S. Dellegrottaglie, T. Losco, L. Casaretti, C. D'Amore, F. Gambardella, M. Prastaro, G. Rengo, D. Leosco, P. Perrone-Filardi, Changes in serum uric acid levels and cardiovascular events: A meta-analysis, Nutrition, Metabolism and Cardiovascular Diseases, 2013, 23, 8, 707

    CrossRef

  15. 15
    Seoyoung C. Kim, Bernhard M. W. Schmidt, Jessica M. Franklin, Jun Liu, Daniel H. Solomon, Sebastian Schneeweiss, Clinical and Health Care Use Characteristics of Patients Newly Starting Allopurinol, Febuxostat, and Colchicine for the Treatment of Gout, Arthritis Care & Research, 2013, 65, 12
  16. 16
    M. A. Becker, P. A. MacDonald, B. J. Hunt, R. L. Jackson, Diabetes and gout: efficacy and safety of febuxostat and allopurinol, Diabetes, Obesity and Metabolism, 2013, 15, 11
  17. 17
    Vytas P. Karalius, David A. Shoham, Dietary Sugar and Artificial Sweetener Intake and Chronic Kidney Disease: A Review, Advances in Chronic Kidney Disease, 2013, 20, 2, 157

    CrossRef

  18. 18
    Hyo Jin Choi, Seung Kak Shin, Mi Ryung Seo, Hee Jung Ryu, Han Joo Baek, Duration of Prophylactic Therapy Affects the Frequency of Gout Flare, Journal of Rheumatic Diseases, 2013, 20, 1, 17

    CrossRef

  19. 19
    Chan Hee Lee, Na Young Sung, Jisoo Lee, Sang-Cheol Bae, Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases, Clinical Rheumatology, 2013, 32, 6, 829

    CrossRef

  20. 20
    Jiunn-Horng Chen, Wen-Harn Pan, Chih-Cheng Hsu, Wen-Ting Yeh, Shao-Yuan Chuang, Pin-Yu Chen, Hui-Chen Chen, Chwen-Tzuei Chang, Wei-Lun Huang, Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study, Arthritis Care & Research, 2013, 65, 1
  21. 21
    Eduardo Massato Hasegawa, Ricardo Fuller, Maria Cristina Chammas, Filipe Martins de Mello, Claudia Goldenstein-Schainberg, Increased prevalence of simple renal cysts in patients with gout, Rheumatology International, 2013, 33, 2, 413

    CrossRef

  22. 22
    Jung-Soo Song, Jae-Bum Jun, Korean Guidelines for Tailored Management of Gout, Journal of Rheumatic Diseases, 2013, 20, 5, 280

    CrossRef

  23. 23
    Iván Ferraz-Amaro, Carlos González-Juanatey, Raquel López-Mejias, Leyre Riancho-Zarrabeitia, Miguel A. González-Gay, Metabolic Syndrome in Rheumatoid Arthritis, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  24. 24
    Antoni Sicras-Mainar, Ruth Navarro-Artieda, Jordi Ibáñez-Nolla, Resource Use and Economic Impact of Patients With Gout: A Multicenter, Population-Wide Study, Reumatología Clínica (English Edition), 2013, 9, 2, 94

    CrossRef

  25. 25
    C.-F. Kuo, K.-H. Yu, L.-C. See, I.-J. Chou, Y.-S. Ko, H.-C. Chang, M.-J. Chiou, S.-F. Luo, Risk of myocardial infarction among patients with gout: a nationwide population-based study, Rheumatology, 2013, 52, 1, 111

    CrossRef

  26. 26
    P. Richette, F. Perez-Ruiz, Serum uric acid and metabolic risk, Current Medical Research and Opinion, 2013, 29, S3, 9

    CrossRef

  27. 27
    Edward Roddy, Sara Muller, Richard Hayward, Christian D Mallen, The association of gout with sleep disorders: a cross-sectional study in primary care, BMC Musculoskeletal Disorders, 2013, 14, 1, 119

    CrossRef

  28. 28
    R. A. Hayward, T. Rathod, E. Roddy, S. Muller, S. L. Hider, C. D. Mallen, The association of gout with socioeconomic status in primary care: a cross-sectional observational study, Rheumatology, 2013, 52, 11, 2004

    CrossRef

  29. 29
    David B. Mount, The kidney in hyperuricemia and gout, Current Opinion in Nephrology and Hypertension, 2013, 22, 2, 216

    CrossRef

  30. 30
    Zhenyu Zhong, Yougang Zhai, Liang Qiao, Transient receptor potential melastatin 2: a novel target for treatment of gout, Expert Opinion on Therapeutic Targets, 2013, 17, 11, 1243

    CrossRef

  31. 31
    Antoni Sicras-Mainar, Ruth Navarro-Artieda, Jordi Ibáñez-Nolla, Uso de recursos e impacto económico de los pacientes con gota: estudio multicéntrico de ámbito poblacional, Reumatología Clínica, 2013, 9, 2, 94

    CrossRef

  32. 32
    Yong Gil Hwang, Kenneth G Saag, Gout, 2013,

    CrossRef

  33. 33
    Tony R Merriman, Cushla McKinney, Gout, 2013,

    CrossRef

  34. 34
    Nauan Fara, Janitzia Vázquez Mellado, Gabriel Sequeira, Eduardo Kerzberg, A Survey on the Current Evaluation and Treatment of Gout in Buenos Aires, Argentina, Reumatología Clínica (English Edition), 2012, 8, 6, 306

    CrossRef

  35. 35
    MD Kontogianni, C Chrysohoou, DB Panagiotakos, E Tsetsekou, A Zeimbekis, C Pitsavos, C Stefanadis, Adherence to the Mediterranean diet and serum uric acid: the ATTICA study, Scandinavian Journal of Rheumatology, 2012, 41, 6, 442

    CrossRef

  36. 36
    Yanyan Zhu, Bhavik J. Pandya, Hyon K. Choi, Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008, The American Journal of Medicine, 2012, 125, 7, 679

    CrossRef

  37. 37
    Jiunn-Horng Chen, Wen-Ting Yeh, Shao-Yuan Chuang, Yi-Ying Wu, Wen-Harn Pan, Gender-specific risk factors for incident gout: a prospective cohort study, Clinical Rheumatology, 2012, 31, 2, 239

    CrossRef

  38. 38
    H.-M. Lai, C.-J. Chen, B. Y.-J. Su, Y.-C. Chen, S.-F. Yu, J.-H. Yen, M.-C. Hsieh, T.-T. Cheng, S.-J. Chang, Gout and Type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences, Rheumatology, 2012, 51, 4, 715

    CrossRef

  39. 39
    Leonardo Punzi, Anna Scanu, Roberta Ramonda, Francesca Oliviero, Gout as autoinflammatory disease: New mechanisms for more appropriated treatment targets, Autoimmunity Reviews, 2012, 12, 1, 66

    CrossRef

  40. 40
    Xiujuan Yao, Zuoqi Ding, Yufeng Xia, Zhifeng Wei, Yubin Luo, Carlos Feleder, Yue Dai, Inhibition of monosodium urate crystal-induced inflammation by scopoletin and underlying mechanisms, International Immunopharmacology, 2012, 14, 4, 454

    CrossRef

  41. 41
    Claudio Annaloro, Lorena Airaghi, Giorgia Saporiti, Francesco Onida, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Metabolic syndrome in patients with hematological diseases, Expert Review of Hematology, 2012, 5, 4, 439

    CrossRef

  42. 42
    D. Winnard, C. Wright, W. J. Taylor, G. Jackson, L. Te Karu, P. J. Gow, B. Arroll, S. Thornley, B. Gribben, N. Dalbeth, National prevalence of gout derived from administrative health data in Aotearoa New Zealand, Rheumatology, 2012, 51, 5, 901

    CrossRef

  43. 43
    E. Suresh, P. Das, Recent advances in management of gout, QJM, 2012, 105, 5, 407

    CrossRef

  44. 44
    Henrik E. Poulsen, Elisabeth Specht, Kasper Broedbaek, Trine Henriksen, Christina Ellervik, Thomas Mandrup-Poulsen, Morten Tonnesen, Peter E. Nielsen, Henrik U. Andersen, Allan Weimann, RNA modifications by oxidation: A novel disease mechanism?, Free Radical Biology and Medicine, 2012, 52, 8, 1353

    CrossRef

  45. 45
    Anthony M. Reginato, David B. Mount, Irene Yang, Hyon K. Choi, The genetics of hyperuricaemia and gout, Nature Reviews Rheumatology, 2012, 8, 10, 610

    CrossRef

  46. 46
    Karina D. Torralba, Emerson Jesus, Shylaja Rachabattula, The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions, International Journal of Rheumatic Diseases, 2012, 15, 6
  47. 47
    Nicola Dalbeth, Karen Lindsay, The Patient’s Experience of Gout: New Insights to Optimize Management, Current Rheumatology Reports, 2012, 14, 2, 173

    CrossRef

  48. 48
    Nauan Fara, Janitzia Vázquez Mellado, Gabriel Sequeira, Eduardo Kerzberg, Una encuesta sobre la evaluación y el tratamiento actual de la gota en Buenos Aires, Argentina, Reumatología Clínica, 2012, 8, 6, 306

    CrossRef

  49. 49
    Ruya Mutluay, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Çitil, Sukru Sindel, Uric Acid is an Important Predictor for Hypertensive Early Atherosclerosis, Advances in Therapy, 2012, 29, 3, 276

    CrossRef

  50. 50
    Hyon K. Choi, Gout & Other Crystal Arthropathies, 2012,

    CrossRef

  51. 51
    Fernando Perez-Ruiz, Loreto Carmona, Maria Jesús García Yébenes, Eliseo Pascual, Eugenio de Miguel, Inmaculada Ureña, Miguel A. González-Gay, An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting, Journal of Clinical Rheumatology, 2011, 17, 7, 349

    CrossRef

  52. 52
    Lucía Cea Soriano, Dietrich Rothenbacher, Hyon K Choi, Luis A García Rodríguez, Contemporary epidemiology of gout in the UK general population, Arthritis Research & Therapy, 2011, 13, 2, R39

    CrossRef

  53. 53
    Naomi Schlesinger, Difficult-to-Treat Gouty Arthritis, Drugs, 2011, 71, 11, 1413

    CrossRef

  54. 54
    Nicola Dalbeth, Kate Palmano, Effects of Dairy Intake on Hyperuricemia and Gout, Current Rheumatology Reports, 2011, 13, 2, 132

    CrossRef

  55. 55
    Chang-Fu Kuo, Kuang-Hui Yu, Lai-Chu See, I-Jun Chou, Wen-Yi Tseng, Hsiao-Chun Chang, Yu-Ming Shen, Shue-Fen Luo, Elevated risk of mortality among gout patients: A comparison with the National Population in Taiwan, Joint Bone Spine, 2011, 78, 6, 577

    CrossRef

  56. 56
    Thomas Bardin, Pascal Richette, Épidémiologie et génétique de la goutte, La Presse Médicale, 2011, 40, 9, 830

    CrossRef

  57. 57
    T. Bardin, A. Cohen-Solal, Goutte et pathologies cardiovasculaires, Revue du Rhumatisme, 2011, 78, S129

    CrossRef

  58. 58
    H.J.E.M. Janssens, Jichtartritis, Huisarts en wetenschap, 2011, 54, 5, 254

    CrossRef

  59. 59
    Robert T. Keenan, William R. O'Brien, Kristen H. Lee, Daria B. Crittenden, Mark C. Fisher, David S. Goldfarb, Svetlana Krasnokutsky, Cheongeun Oh, Michael H. Pillinger, Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout, The American Journal of Medicine, 2011, 124, 2, 155

    CrossRef

  60. 60
    Yanyan Zhu, Bhavik J. Pandya, Hyon K. Choi, Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008, Arthritis & Rheumatism, 2011, 63, 10
  61. 61
    Jung-Soo Song, Rising Gout, Life Threatening Public Enemy, Journal of Rheumatic Diseases, 2011, 18, 4, 234

    CrossRef

  62. 62
    Chang-Fu Kuo, Kuang-Hui Yu, Lai-Chu See, I-Jun Chou, Wen-Yi Tseng, Hsiao-Chun Chang, Yu-Ming Shen, Shue-Fen Luo, Risqué élevé de mortalité chez les patients goutteux : une comparaison avec la population nationale taïwanaise, Revue du Rhumatisme, 2011, 78, 5, 437

    CrossRef

  63. 63
    Sophia Li, Robert Micheletti, Role of Diet in Rheumatic Disease, Rheumatic Disease Clinics of North America, 2011, 37, 1, 119

    CrossRef

  64. 64
    So Young Jo, Yong-Beom Park, Chan Hee Lee, The Effect of Hypouricemic Treatment on the Renal Function in Patients with Gout, Journal of Rheumatic Diseases, 2011, 18, 1, 26

    CrossRef

  65. 65
    Young Hee Rho, Yanyan Zhu, Hyon K. Choi, The Epidemiology of Uric Acid and Fructose, Seminars in Nephrology, 2011, 31, 5, 410

    CrossRef

  66. 66
    Tony R. Merriman, Nicola Dalbeth, The genetic basis of hyperuricaemia and gout, Joint Bone Spine, 2011, 78, 1, 35

    CrossRef

  67. 67
    Chan Hee Lee, Na Young Sung, The Prevalence and Features of Korean Gout Patients Using the National Health Insurance Corporation Database, Journal of Rheumatic Diseases, 2011, 18, 2, 94

    CrossRef

  68. 68
    Eswar Krishnan, Jeremy Sokolove, Uric acid in heart disease: a new C-reactive protein?, Current Opinion in Rheumatology, 2011, 23, 2, 174

    CrossRef

  69. 69
    Hyon K Choi, A prescription for lifestyle change in patients with hyperuricemia and gout, Current Opinion in Rheumatology, 2010, 22, 2, 165

    CrossRef

  70. 70
    Tony R. Merriman, Nicola Dalbeth, Bases génétiques de l’hyperuricémie et de la goutte, Revue du Rhumatisme Monographies, 2010, 77, 4, 328

    CrossRef

  71. 71
    H. H. Dao, M. Harun-Or-Rashid, J. Sakamoto, Body composition and metabolic syndrome in patients with primary gout in Vietnam, Rheumatology, 2010, 49, 12, 2400

    CrossRef

  72. 72
    Andrew Whelton, Current and Future Therapeutic Options for the Management of Gout, American Journal of Therapeutics, 2010, 1

    CrossRef

  73. 73
    E.U.R. Smith, C. Díaz-Torné, F. Perez-Ruiz, L.M. March, Epidemiology of gout: An update, Best Practice & Research Clinical Rheumatology, 2010, 24, 6, 811

    CrossRef

  74. 74
    Hyon K Choi, Yanyan Zhu, David B Mount, Genetics of gout, Current Opinion in Rheumatology, 2010, 22, 2, 144

    CrossRef

  75. 75
    Pascal Richette, Thomas Bardin, Gout, The Lancet, 2010, 375, 9711, 318

    CrossRef

  76. 76
    C-F Kuo, K-H Yu, S-F Luo, C-T Chiu, Y-S Ko, J-S Hwang, W-Y Tseng, H-C Chang, H-W Chen, L-C See, Gout and risk of non-alcoholic fatty liver disease, Scandinavian Journal of Rheumatology, 2010, 39, 6, 466

    CrossRef

  77. 77
    C.-F. Kuo, L.-C. See, S.-F. Luo, Y.-S. Ko, Y.-S. Lin, J.-S. Hwang, C.-M. Lin, H.-W. Chen, K.-H. Yu, Gout: an independent risk factor for all-cause and cardiovascular mortality, Rheumatology, 2010, 49, 1, 141

    CrossRef

  78. 78
    Taku Inokuchi, Zenta Tsutsumi, Sumio Takahashi, Tsuneyoshi Ka, Yuji Moriwaki, Tetsuya Yamamoto, Increased Frequency of Metabolic Syndrome and Its Individual Metabolic Abnormalities in Japanese Patients With Primary Gout, JCR: Journal of Clinical Rheumatology, 2010, 16, 3, 109

    CrossRef

  79. 79
    J. M. Fraile, R. J. Torres, Mendieta E. de Miguel, P. Martínez, K. J. Lundelin, J. J. Vázquez, J. G. Puig, Metabolic Syndrome Characteristics in Gout Patients, Nucleosides, Nucleotides and Nucleic Acids, 2010, 29, 4-6, 325

    CrossRef

  80. 80
    E. Roddy, C. D. Mallen, S. L. Hider, K. P. Jordan, Prescription and comorbidity screening following consultation for acute gout in primary care, Rheumatology, 2010, 49, 1, 105

    CrossRef

  81. 81
    Dorota Lebiedz-Odrobina, Jonathan Kay, Rheumatic Manifestations of Diabetes Mellitus, Rheumatic Disease Clinics of North America, 2010, 36, 4, 681

    CrossRef

  82. 82
    M. S. Hershfield, L. J. Roberts, N. J. Ganson, S. J. Kelly, I. Santisteban, E. Scarlett, D. Jaggers, J. S. Sundy, Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo, Proceedings of the National Academy of Sciences, 2010, 107, 32, 14351

    CrossRef

  83. 83
    Tony C Ning, Robert T Keenan, Unusual clinical presentations of gout, Current Opinion in Rheumatology, 2010, 22, 2, 181

    CrossRef

  84. 84
    Claudia Berenice Hernández-Cuevas, Lizandra Hernández Roque, Gabriela Huerta-Sil, Jorge Rojas-Serrano, Alejandro Escudero, Letícia Lino Perez, Eduardo Collantes-Estevez, Janitzia Vázquez Mellado, First Acute Gout Attacks Commonly Precede Features of the Metabolic Syndrome, JCR: Journal of Clinical Rheumatology, 2009, 15, 2, 65

    CrossRef

  85. 85
    Robert Terkeltaub, David Zelman, John Scavulli, Fernando Perez-Ruiz, Frédéric Lioté, Gout Study Group: Update on hyperuricemia and gout, Joint Bone Spine, 2009, 76, 4, 444

    CrossRef

  86. 86
    Eliseo Pascual, Francisca Sivera, Gout: new advances in the diagnosis and management of an old disease, International Journal of Clinical Rheumatology, 2009, 4, 2, 203

    CrossRef

  87. 87
    Savvas Nicolaou, Daniel J Hou, Imaging gout: brought back to the forefront with dual-energy computed tomography, Imaging in Medicine, 2009, 1, 2, 119

    CrossRef

  88. 88
    M. Winzer, A.-K. Tausche, M. Aringer, Kristallinduzierte Inflammasomaktivierung: Gicht und Pseudogicht, Zeitschrift für Rheumatologie, 2009, 68, 9, 733

    CrossRef

  89. 89
    Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho, Eloísa Bonfá, Metabolic syndrome in rheumatological diseases, Autoimmunity Reviews, 2009, 8, 5, 415

    CrossRef

  90. 90
    M. Doherty, New insights into the epidemiology of gout, Rheumatology, 2009, 48, suppl 2, ii2

    CrossRef

  91. 91
    Jiunn-Horng Chen, Shao-Yuan Chuang, Hsin-Jen Chen, Wen-Ting Yeh, Wen-Harn Pan, Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A chinese cohort study, Arthritis Care & Research, 2009, 61, 2
  92. 92
    OB Omole, GA Ogunbanjo, The evolution of gout (an old lifestyle disease), South African Family Practice, 2009, 51, 5, 396

    CrossRef

  93. 93
    Ajit Menon, Edward Roddy, Update on factors predisposing to gout, International Journal of Clinical Rheumatology, 2009, 4, 1, 75

    CrossRef

  94. 94
    N. Dalbeth, T. Merriman, Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout, Rheumatology, 2008, 48, 3, 222

    CrossRef

  95. 95
    Lan X. Chen, H Ralph Schumacher, Gout, JCR: Journal of Clinical Rheumatology, 2008, 14, Supplement, S55

    CrossRef

  96. 96
    H. K. Choi, M. A. De Vera, E. Krishnan, Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile, Rheumatology, 2008, 47, 10, 1567

    CrossRef

  97. 97
    Arthur L. Weaver, Michelle A. Cheh, Richard H. Kennison, How PCP Education Can Impact Gout Management, JCR: Journal of Clinical Rheumatology, 2008, 14, Supplement, S42

    CrossRef

  98. 98
    Juan García Puig, María Angeles Martínez, Hyperuricemia, gout and the metabolic syndrome, Current Opinion in Rheumatology, 2008, 20, 2, 187

    CrossRef

  99. 99
    A Elisabeth Hak, Hyon K Choi, Lifestyle and gout, Current Opinion in Rheumatology, 2008, 20, 2, 179

    CrossRef

  100. 100
    Jee Woong J. Choi, Earl S. Ford, Xiang Gao, Hyon K. Choi, Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The third national health and nutrition examination survey, Arthritis Care & Research, 2008, 59, 1
  101. 101
    High prevalence of metabolic syndrome in patients with gout or SLE, Nature Clinical Practice Rheumatology, 2007, 3, 5, 250

    CrossRef

  102. 102
    Hyon K. Choi, Earl S. Ford, Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia, The American Journal of Medicine, 2007, 120, 5, 442

    CrossRef

  103. 103
    Andrew Grey, Nicola Dalbeth, Bone and Rheumatic Disorders in Diabetes,
  104. 104
    John HY Moi, Melonie K Sriranganathan, Christopher J Edwards, Rachelle Buchbinder, Lifestyle interventions for acute gout, The Cochrane Library,
  105. 105
    John HY Moi, Melonie K Sriranganathan, Christopher J Edwards, Rachelle Buchbinder, Lifestyle interventions for acute gout, The Cochrane Library,